RenovaCare, Inc. announced the official launch of its new RenovaCare R&D Innovation Center in Berlin, Germany, where the Company’s patented technologies for isolating and spraying self-donated stem cells to regenerate tissues and organs have been under development alongside new product initiatives. Important programs at the Center include preclinical support to RenovaCare regulatory submissions for its SkinGun, which delivers a proprietary gentle CellMist spray of a patient’s own skin cells on to burns and wounds. The Innovation Center is the result of a new multi-year collaboration agreement with StemCell Systems GmbH, the Company’s long-standing strategic partner since 2014, and inventors and developers of the patented RenovaCare SkinGun™ and proprietary triple-enzyme cell isolation, CellMist™. From inception, this successful relationship with StemCell Systems has proven a resource-efficient, contemporary approach to maximizing RenovaCare research and development dollars.  The new Innovation Center houses dedicated RenovaCare cell biology laboratories; additional engineering, fabrication, prototyping and performance testing facilities; and product design studios for medical devices and biomedical products. Experienced contract bioengineers, cell biologists, and support staff work under the direction of a team of MD-PhDs who are experts in regenerative medicine, new product development, and clinical translation.